A1A8P

2-[3-[[2-azanyl-7-[(5-chloranyl-1-benzofuran-2-yl)methyl]-6-oxidanylidene-1~{H}-purin-9-yl]methyl]phenyl]ethylphosphonic acid

Created:	2024-09-20
Last modified:	2025-01-29

Find Related PDB Entry
1 entries where A1A8P is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	1
Atom Count	57
Chiral Atom Count	0
Bond Count	61
Aromatic Bond Count	21

2D diagram of A1A8P

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-[3-[[2-azanyl-7-[(5-chloranyl-1-benzofuran-2-yl)methyl]-6-oxidanylidene-1~{H}-purin-9-yl]methyl]phenyl]ethylphosphonic acid
Systematic Name (OpenEye OEToolkits)	2-[3-[[2-azanyl-7-[(5-chloranyl-1-benzofuran-2-yl)methyl]-6-oxidanylidene-1~{H}-purin-7-ium-9-yl]methyl]phenyl]ethylphosphonic acid
Formula	C₂₃ H₂₂ Cl N₅ O₅ P
Molecular Weight	514.878
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	14.52	O=P(O)(O)CCc1cccc(c1)Cn1c[n+](Cc2cc3cc(Cl)ccc3o2)c2C(=O)NC(N)=Nc21
SMILES	CACTVS	3.385	NC1=Nc2n(Cc3cccc(CC[P](O)(O)=O)c3)c[n+](Cc4oc5ccc(Cl)cc5c4)c2C(=O)N1
SMILES	OpenEye OEToolkits	2.0.7	c1cc(cc(c1)Cn2c[n+](c3c2N=C(NC3=O)N)Cc4cc5cc(ccc5o4)Cl)CCP(=O)(O)O
Canonical SMILES	CACTVS	3.385	NC1=Nc2n(Cc3cccc(CC[P](O)(O)=O)c3)c[n+](Cc4oc5ccc(Cl)cc5c4)c2C(=O)N1
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1cc(cc(c1)Cn2c[n+](c3c2N=C(NC3=O)N)Cc4cc5cc(ccc5o4)Cl)CCP(=O)(O)O
InChI	InChI	1.06	InChI=1S/C23H21ClN5O5P/c24-17-4-5-19-16(9-17)10-18(34-19)12-28-13-29(21-20(28)22(30)27-23(25)26-21)11-15-3-1-2-14(8-15)6-7-35(31,32)33/h1-5,8-10,13H,6-7,11-12H2,(H4-,25,26,27,30,31,32,33)/p+1
InChIKey	InChI	1.06	LOKWXOGCATZPBT-UHFFFAOYSA-O

Related Resource References

Resource Name	Reference
PubChem	172643913

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.